Articles dans des revues avec comité de lecture (120)
58.
Vaes, M., Hites, M., Cotton, F., Bourguignon, A., Csergo, M., Rasson, C., Ameye, L., Bron, D., Jacobs, F., & Aoun, M. (2012). Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome. Antimicrobial agents and chemotherapy, 56(12), 6298-6303. doi:10.1128/AAC.01177-1261.
Taccone, F., Cotton, F., Roisin, S., Vincent, J. L., & Jacobs, F. (2012). Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock. Antimicrobial agents and chemotherapy, 56(4), 2129-2131. doi:10.1128/AAC.06389-1162.
Rodriguez, A., Kouegnigan, L., Fester, A., Cotton, F., & Duez, P. (2012). Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients. Hemoglobin, 36(6), 545-554.63.
Ocampos-Martinez, E., Penaccini, L., Scolletta, S., Abdelhadii, A., Devigili, A., Cianferoni, S., De Backer, D., Jacobs, F., Cotton, F., Vincent, J. L., & Taccone, F. (2012). Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. International journal of antimicrobial agents, 39(4), 332-337.64.
Rimachi Alvarez, R., Bruzzi de Carvalho, F., Orellano-Jimenez, C., Cotton, F., Vincent, J. L., & De Backer, D. (2012). Lactate/pyruvate ratio as a marker of tissue hypoxia in circulatory and septic shock. Anaesthesia and intensive care, 40(3), 427-432.65.
Piagnerelli, M., Cotton, F., Van Nuffelen, M., Vincent, J. L., & Gulbis, B. (2012). Modifications in erythrocyte membrane protein content are not responsible for the alterations in rheology seen in sepsis. Shock, 37(1), 17-21. doi:10.1097/SHK.0b013e318237d55a66.
Bizumukama, L., Ferster, A., Gulbis, B., Kumps, A., & Cotton, F. (2011). Effects of disodium cromoglycate on cationic exchange of deoxygenated sickle cells. European journal of pharmacology, 665(1-3), 13-18. doi:10.1016/j.ejphar.2011.05.00767.
Seyler, L., Cotton, F., Taccone, F., De Backer, D., Macours, P., Vincent, J. L., & Jacobs, F. (2011). Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Critical care, 15(3), R137. doi:10.1186/cc1025769.
Kabtouri, H., Taccone, F., Cotton, F., Vincent, J. L., & Jacobs, F. (2011). High regimen of continuous infusion of vancomycin in septic patients. Intensive care medicine, 37(1), 264.